Aging promotes accumulation of senescent and multiciliated cells in human endometrial epithelium.

aging assisted reproduction endometrial receptivity endometrium gene expression immunohistochemistry

Journal

Human reproduction open
ISSN: 2399-3529
Titre abrégé: Hum Reprod Open
Pays: England
ID NLM: 101722764

Informations de publication

Date de publication:
2024
Historique:
received: 17 11 2023
revised: 26 06 2024
medline: 26 8 2024
pubmed: 26 8 2024
entrez: 26 8 2024
Statut: epublish

Résumé

What changes occur in the endometrium during aging, and do they impact fertility? Both the transcriptome and cellular composition of endometrial samples from women of advanced maternal age (AMA) are significantly different from that of samples from young women, suggesting specific changes in epithelial cells that may affect endometrial receptivity. Aging is associated with the accumulation of senescent cells in aging tissues. Reproductive aging is mostly attributed to the decline in ovarian reserve and oocyte quality, whereas the endometrium is a unique complex tissue that is monthly renewed under hormonal regulation. Several clinical studies have reported lower implantation and pregnancy rates in oocyte recipients of AMA during IVF. Molecular studies have indicated the presence of specific mutations within the epithelial cells of AMA endometrium, along with altered gene expression of bulk endometrial tissue. Endometrial transcriptome profiling was performed for 44 women undergoing HRT during the assessment of endometrial receptivity before IVF. Patients younger than 28 years were considered as the young maternal age (YMA) group (age 23-27 years) and women older than 45 years were considered as the AMA group (age 47-50 years). Endometrial biopsies were obtained on Day 5 of progesterone treatment and RNA was extracted. All endometrial samples were evaluated as being receptive based on the expression of 68 common endometrial receptivity markers. Endometrial samples from another 24 women classified into four age groups (YMA, intermediate age group 1 (IMA1, age 29-35), intermediate age group 2 (IMA2, age 36-44), and AMA) were obtained in the mid-secretory stage of a natural cycle (NC) and used for validation studies across the reproductive lifespan. A total of 24 HRT samples (12 YMA and 12 AMA) were subject to RNA sequencing (RNA-seq) and differential gene expression analysis, 20 samples (10 YMA and 10 AMA) were used for qPCR validation, and 24 NC samples (6 YMA, 6 IMA1, 6 IMA2 and 6AMA) were used for RNA-seq validation of AMA genes across the woman's reproductive lifespan. Immunohistochemistry (IHC) was used to confirm some expression changes at the protein level. Computational deconvolution using six endometrial cell type-specific transcriptomic profiles was conducted to compare the cellular composition between the groups. Comparisons between YMA and AMA samples identified a lower proportion of receptive endometria in the AMA group ( The raw sequencing data reported in this article are deposited at the Gene Expression Omnibus under accession code GSE236128. This retrospective study identified changes in the endometrium of patients undergoing hormonal replacement and validated these changes using samples obtained during a NC. However, future studies must clarify the importance of these findings on the clinical outcomes of assisted reproduction. The findings reported in this study have important implications for devising future strategies aimed at improving fertility management in women of advanced reproductive age. This research was funded by the Estonian Research Council (grant no. PRG1076), Horizon 2020 innovation grant (ERIN, grant no. EU952516), Enterprise Estonia (grant no. EU48695), MSCA-RISE-2020 project TRENDO (grant no. 101008193), EU 874867 project HUTER, the Horizon Europe NESTOR grant (grant no. 101120075) of the European Commission, the EVA specialty program (grant no. KP111513) of the Maastricht University Medical Center (MUMC+), MICIU/AEI/10.13039/501100011033 and FEDER, EU projects Endo-Map (grant no. PID2021-12728OB-100), ROSY (grant no. CNS2022-135999), and the National Science Fund of Bulgaria (grant no. KII-06 H31/2). The authors declare no competing interests.

Identifiants

pubmed: 39185250
doi: 10.1093/hropen/hoae048
pii: hoae048
pmc: PMC11344589
doi:

Types de publication

Journal Article

Langues

eng

Pagination

hoae048

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Auteurs

Marina Loid (M)

Department of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
Competence Centre on Health Technologies, Tartu, Estonia.

Darina Obukhova (D)

Department of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
Department of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Department of Genetics and Cell Biology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.

Keiu Kask (K)

Department of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
Competence Centre on Health Technologies, Tartu, Estonia.

Apostol Apostolov (A)

Department of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
Competence Centre on Health Technologies, Tartu, Estonia.

Alvin Meltsov (A)

Competence Centre on Health Technologies, Tartu, Estonia.
Department of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Department of Genetics and Cell Biology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.

Demis Tserpelis (D)

Department of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Arthur van den Wijngaard (A)

Department of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Signe Altmäe (S)

Department of Biochemistry and Molecular Biology, Faculty of Sciences, University of Granada, Granada, Spain.
Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Galina Yahubyan (G)

Department of Molecular Biology, Faculty of Biology, University of Plovdiv, Plovdiv, Bulgaria.

Vesselin Baev (V)

Department of Molecular Biology, Faculty of Biology, University of Plovdiv, Plovdiv, Bulgaria.

Merli Saare (M)

Department of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
Competence Centre on Health Technologies, Tartu, Estonia.

Maire Peters (M)

Department of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
Competence Centre on Health Technologies, Tartu, Estonia.

Ave Minajeva (A)

Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.

Priit Adler (P)

Faculty of Science and Technology, Institute of Computer Science, University of Tartu, Tartu, Estonia.

Ganesh Acharya (G)

Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Kaarel Krjutškov (K)

Department of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
Competence Centre on Health Technologies, Tartu, Estonia.

Maria Nikolova (M)

Department of Molecular Biology, Faculty of Biology, University of Plovdiv, Plovdiv, Bulgaria.
Center for Women's Health, Plovdiv, Bulgaria.

Felipe Vilella (F)

Research & Medical Department, Carlos Simon Foundation, INCLIVA Health Research Institute, Valencia, Spain.

Carlos Simon (C)

Research & Medical Department, Carlos Simon Foundation, INCLIVA Health Research Institute, Valencia, Spain.
Beth Israel Deaconess Medical Center, Harvard University, Boston, MA, USA.
Department of Pediatrics, Obstetrics & Gynecology, University of Valencia, Valencia, Spain.
Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX, USA.

Masoud Zamani Esteki (M)

Department of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Department of Genetics and Cell Biology, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Andres Salumets (A)

Department of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
Competence Centre on Health Technologies, Tartu, Estonia.
Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

Classifications MeSH